499142-86-8

Upstream product

• 24558-77-8 3,4,5,6-tetra-O-benzyl inositol 
• 68275-40-1 trimethyl orthohexadecanoate 
• 64681-28-3 D-1-O-allyl-3,4,5,6-tetra-O-benzyl-myo-inositol 

Downstream Products

• 1035456-80-4 3,4,5,6-tetra-O-benzyl-1-O-(dibenzylphosphono)-2-(9-palmitoyl)-myo-inositol 
• 499142-87-9 Hexadecanoic acid (1R,2R,3S,4S,5R,6S)-2,3,4,5-tetrakis-benzyloxy-6-[benzyloxy-((R)-2-hexadecanoyloxy-3-hexanoyloxy-propoxy)-phosphoryloxy]-cyclohexyl ester 
• 499142-83-5 benzyloxy-[2-O-palmitoyl-3,4,5,6-tetra-O-benzyl-D-myo-inosityl]-(N,N-diisoepropylamino)phosphine 

Relevant academic research and scientific papers

SYNTHETIC LIPOPHILIC INOSITOL GLYCANS FOR TREATMENT OF CANCER AND GLUCOSE-METABOLISM DISORDERS

The present intervention related to materials and methods for the synthesis of lipophilic inositol glycan compounds, and salts, solvates and physiological functional derivatives thereof, and their use for the treatment of cancer and glucose-metabolism disorders, such as, for example, diabetes, obesity and metabolic syndrome.

Synthetic approaches to heavily lipidated phosphoglyceroinositides

(Matrix presented) Naturally occurring phosphoinositide glycoconjugates are equipped with varied acyl residues that are important for their biological activity and biosynthesis. This paper reports that acylation at O2 of the myo-inositol moiety can be ach